These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 27484959)

  • 1. Modulation of type 1 and type 2 diabetes risk by the intestinal microbiome.
    Paun A; Danska JS
    Pediatr Diabetes; 2016 Nov; 17(7):469-477. PubMed ID: 27484959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune recognition and response to the intestinal microbiome in type 1 diabetes.
    Paun A; Yau C; Danska JS
    J Autoimmun; 2016 Jul; 71():10-8. PubMed ID: 26908163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gut microbiome and elevated cardiovascular risk in obesity and autoimmunity.
    Kasselman LJ; Vernice NA; DeLeon J; Reiss AB
    Atherosclerosis; 2018 Apr; 271():203-213. PubMed ID: 29524863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiome and type 2 diabetes: where we are and where to go?
    Sharma S; Tripathi P
    J Nutr Biochem; 2019 Jan; 63():101-108. PubMed ID: 30366260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunometabolism of obesity and diabetes: microbiota link compartmentalized immunity in the gut to metabolic tissue inflammation.
    McPhee JB; Schertzer JD
    Clin Sci (Lond); 2015 Dec; 129(12):1083-96. PubMed ID: 26464517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Influence of the Microbiome on Type 1 Diabetes.
    Paun A; Yau C; Danska JS
    J Immunol; 2017 Jan; 198(2):590-595. PubMed ID: 28069754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes.
    Scheithauer TPM; Rampanelli E; Nieuwdorp M; Vallance BA; Verchere CB; van Raalte DH; Herrema H
    Front Immunol; 2020; 11():571731. PubMed ID: 33178196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting gut microbiota as a possible therapy for diabetes.
    He C; Shan Y; Song W
    Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiome may contribute to insulin resistance and systemic inflammation in obese rodents: a meta-analysis.
    Jiao N; Baker SS; Nugent CA; Tsompana M; Cai L; Wang Y; Buck MJ; Genco RJ; Baker RD; Zhu R; Zhu L
    Physiol Genomics; 2018 Apr; 50(4):244-254. PubMed ID: 29373083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of gut microbiota in mediating obesity and diabetes mellitus.
    Pitocco D; Di Leo M; Tartaglione L; De Leva F; Petruzziello C; Saviano A; Pontecorvi A; Ojetti V
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1548-1562. PubMed ID: 32096204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota and type 2 diabetes mellitus.
    Muñoz-Garach A; Diaz-Perdigones C; Tinahones FJ
    Endocrinol Nutr; 2016 Dec; 63(10):560-568. PubMed ID: 27633134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging role of intestinal microbiota and microbial metabolites in metabolic control.
    Herrema H; IJzerman RG; Nieuwdorp M
    Diabetologia; 2017 Apr; 60(4):613-617. PubMed ID: 28013341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the Gut Microbiome in the Pathogenesis of Obesity and Obesity-Related Metabolic Dysfunction.
    Bouter KE; van Raalte DH; Groen AK; Nieuwdorp M
    Gastroenterology; 2017 May; 152(7):1671-1678. PubMed ID: 28192102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk.
    Miele L; Giorgio V; Alberelli MA; De Candia E; Gasbarrini A; Grieco A
    Curr Cardiol Rep; 2015 Dec; 17(12):120. PubMed ID: 26497040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a role for gut microbiota in type 1 diabetes pathogenesis?
    Bibbò S; Dore MP; Pes GM; Delitala G; Delitala AP
    Ann Med; 2017 Feb; 49(1):11-22. PubMed ID: 27499366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk between intestinal microbiota, adipose tissue and skeletal muscle as an early event in systemic low-grade inflammation and the development of obesity and diabetes.
    Bleau C; Karelis AD; St-Pierre DH; Lamontagne L
    Diabetes Metab Res Rev; 2015 Sep; 31(6):545-61. PubMed ID: 25352002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the Gastrointestinal Tract Microbiome in the Pathophysiology of Diabetes Mellitus.
    Sohail MU; Althani A; Anwar H; Rizzi R; Marei HE
    J Diabetes Res; 2017; 2017():9631435. PubMed ID: 29082264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diet, gut microbiota and cognition.
    Proctor C; Thiennimitr P; Chattipakorn N; Chattipakorn SC
    Metab Brain Dis; 2017 Feb; 32(1):1-17. PubMed ID: 27709426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Gut Microbiota in the development of obesity and Diabetes.
    Baothman OA; Zamzami MA; Taher I; Abubaker J; Abu-Farha M
    Lipids Health Dis; 2016 Jun; 15():108. PubMed ID: 27317359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.